Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 3/20 | 0.38 |
| ▸ | MMP9 | P14780 | 3/20 | 0.38 |
| ▸ | MMP8 | P22894 | 2/20 | 0.38 |
| ▸ | MMP13 | P45452 | 2/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | PDK2 | Q15119 | 5/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | GPR3 | P46089 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14750205 | 1.00 | MMP2 (0.38) | MMP2MMP9MMP8MMP13APEX1 | |
| SCHEMBL1356093 | 1.00 | MMP2 (0.38) | MMP2MMP9MMP8MMP13APEX1 | |
| SCHEMBL14750260 | 1.00 | MMP2 (0.38) | MMP2MMP9MMP8MMP13APEX1 | |
| SCHEMBL9101904 | 0.93 | MMP2 (0.36) | MMP2MMP9MMP8MMP13TDP1 | |
| SCHEMBL18894239 | 0.93 | MMP2 (0.36) | MMP2MMP9MMP8MMP13TDP1 | |
| SCHEMBL851336 | 0.93 | MMP2 (0.36) | MMP2MMP9MMP8MMP13TDP1 | |
| SCHEMBL30435044 | 0.93 | MMP2 (0.36) | MMP2MMP9MMP8MMP13TDP1 | |
| SCHEMBL6658545 | 0.93 | MMP2 (0.36) | MMP2MMP9MMP8MMP13TDP1 | |
| SCHEMBL26109311 | 0.90 | MMP2 (0.35) | MMP2MMP9MMP8MMP13TDP1 | |
| Benzaldehyde SCHEMBL28219884 | 0.87 | APEX1 (0.44) | MMP2MMP9MMP8MMP13APEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120100628-A1 | EMISSIVE AND BROADBAND NONLINEAR ABSORBING METAL COMPLEXES AND LIGANDS AS OLED, OPTICAL SWITCHING OR OPTICAL SENSING MATERIALS | NDSU RESEARCH FOUNDATION (US) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120100628-A1 | EMISSIVE AND BROADBAND NONLINEAR ABSORBING METAL COMPLEXES AND LIGANDS AS OLED, OPTICAL SWITCHING OR OPTICAL SENSING MATERIALS | OCIAD2, OCIAD1, NONO | MMP2 4820/4885MMP9 2459/4885MMP8 4610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.